Multi-target drugs to address multiple checkpoints in complex inflammatory pathologies: evolutionary cues for novel “first-in-class” anti-inflammatory drug candidates: a reviewer’s perspective

G. Mathew, M.K. Unnikrishnan

Research output: Contribution to journalArticle

9 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)747-752
Number of pages6
JournalInflammation Research
Volume64
Issue number10
DOIs
Publication statusPublished - 2015
Externally publishedYes

Cite this